Pomanda estimates the enterprise value of NATIONAL MEDICAL REPORTING LTD at £23.4k based on a Turnover of £57.9k and 0.4x industry multiple (adjusted for size and gross margin).
national medical reporting ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of NATIONAL MEDICAL REPORTING LTD at £0 based on an EBITDA of £-5.6k and a 3.11x industry multiple (adjusted for size and gross margin).
national medical reporting ltdEstimated Valuation
£16.2k
Pomanda estimates the enterprise value of NATIONAL MEDICAL REPORTING LTD at £16.2k based on Net Assets of £6.9k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
National Medical Reporting LtdOverview
National Medical Reporting Ltd is a live company located in birmingham, B13 8LX with a Companies House number of 09713861. It operates in the other human health activities sector, SIC Code 86900. Founded in August 2015, it's largest shareholder is
azra yousaf
with a 50% stake. National Medical Reporting Ltd is a established,
micro sized company, Pomanda has estimated its turnover at
£57.9k with
declining
growth in recent years.
Pomanda's financial health check has awarded National Medical Reporting Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
Health Rating1.5out of 5
1 Strong
1 Regular
7 Weak
Size
annual sales of £57.9k, make it smaller than the average company (£686.3k)
£57.9k - National Medical Reporting Ltd
£686.3k - Industry AVG
Growth
3 year (CAGR) sales growth of -6%, show it is growing at a slower rate (8%)
-6% - National Medical Reporting Ltd
8% - Industry AVG
Production
with a gross margin of 23.1%, this company has a higher cost of product (38.9%)
23.1% - National Medical Reporting Ltd
38.9% - Industry AVG
Profitability
an operating margin of -9.6% make it less profitable than the average company (5.4%)
-9.6% - National Medical Reporting Ltd
5.4% - Industry AVG
Employees
with 2 employees, this is below the industry average (18)
2 - National Medical Reporting Ltd
18 - Industry AVG
Pay Structure
on an average salary of £27.4k, the company has an equivalent pay structure (£27.4k)
£27.4k - National Medical Reporting Ltd
£27.4k - Industry AVG
Efficiency
resulting in sales per employee of £28.9k, this is less efficient (£49k)
£28.9k - National Medical Reporting Ltd
£49k - Industry AVG
Debtor Days
it gets paid by customers after 31 days, this is later than average (20 days)
31 days - National Medical Reporting Ltd
20 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - National Medical Reporting Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - National Medical Reporting Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - National Medical Reporting Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 12.8%, this is a lower level of debt than the average (24.7%)
12.8% - National Medical Reporting Ltd
24.7% - Industry AVG
NATIONAL MEDICAL REPORTING LTD financials
EXPORT
National Medical Reporting Ltd's latest turnover from July 2024 is estimated at £57.9 thousand and the company has net assets of £6.9 thousand. According to their latest financial statements, National Medical Reporting Ltd has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jul 2024
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Turnover
57,864
67,539
51,133
69,853
63,712
102,266
107,991
105,973
47,957
Other Income Or Grants
Cost Of Sales
44,490
52,899
40,114
56,441
49,990
80,462
84,500
80,289
36,770
Gross Profit
13,374
14,640
11,019
13,412
13,722
21,805
23,491
25,685
11,188
Admin Expenses
18,954
11,384
16,448
13,804
15,951
18,110
9,922
23,223
8,595
Operating Profit
-5,580
3,256
-5,429
-392
-2,229
3,695
13,569
2,462
2,593
Interest Payable
Interest Receivable
16
32
Pre-Tax Profit
-5,580
3,256
-5,429
-392
-2,229
3,695
13,569
2,478
2,625
Tax
-814
-702
-2,578
-471
-525
Profit After Tax
-5,580
2,442
-5,429
-392
-2,229
2,993
10,991
2,007
2,100
Dividends Paid
Retained Profit
-5,580
2,442
-5,429
-392
-2,229
2,993
10,991
2,007
2,100
Employee Costs
54,824
51,717
48,834
46,987
46,022
45,256
43,536
42,957
20,562
Number Of Employees
2
2
2
2
2
2
2
2
1
EBITDA*
-5,580
3,256
-5,429
-392
-2,229
3,695
13,569
2,462
3,071
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jul 2024
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Tangible Assets
2,855
3,807
5,076
5,861
6,055
604
806
1,075
1,433
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
2,855
3,807
5,076
5,861
6,055
604
806
1,075
1,433
Stock & work in progress
Trade Debtors
5,058
9,535
4,965
11,141
13,181
20,777
20,468
17,272
Group Debtors
Misc Debtors
Cash
12,994
misc current assets
total current assets
5,058
9,535
4,965
11,141
13,181
20,777
20,468
17,272
12,994
total assets
7,913
13,342
10,041
17,002
19,236
21,381
21,274
18,347
14,427
Bank overdraft
Bank loan
Trade Creditors
3,374
3,290
6,176
14,240
12,227
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
3,374
3,290
6,176
14,240
12,227
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
1,010
859
1,532
provisions
total long term liabilities
1,010
859
1,532
total liabilities
1,010
859
1,532
3,374
3,290
6,176
14,240
12,227
net assets
6,903
12,483
10,041
15,470
15,862
18,091
15,098
4,107
2,200
total shareholders funds
6,903
12,483
10,041
15,470
15,862
18,091
15,098
4,107
2,200
Jul 2024
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Operating Activities
Operating Profit
-5,580
3,256
-5,429
-392
-2,229
3,695
13,569
2,462
2,593
Depreciation
478
Amortisation
Tax
-814
-702
-2,578
-471
-525
Stock
Debtors
-4,477
4,570
-6,176
-2,040
-7,596
309
3,196
17,272
Creditors
-3,374
84
-2,886
-8,064
2,013
12,227
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
-1,103
-2,128
747
-1,726
5,451
-202
-269
-13,268
14,773
Investing Activities
capital expenditure
952
1,269
785
194
-5,451
202
269
358
-1,911
Change in Investments
cash flow from investments
952
1,269
785
194
-5,451
202
269
358
-1,911
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
151
859
-1,532
1,532
share issue
-100
100
interest
16
32
cash flow from financing
151
859
-1,532
1,532
-84
132
cash and cash equivalents
cash
-12,994
12,994
overdraft
change in cash
-12,994
12,994
national medical reporting ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for national medical reporting ltd. Get real-time insights into national medical reporting ltd's credit score, group structure and payment trends.
National Medical Reporting Ltd Competitor Analysis
Perform a competitor analysis for national medical reporting ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in B13 area or any other competitors across 12 key performance metrics.
national medical reporting ltd Ownership
NATIONAL MEDICAL REPORTING LTD group structure
National Medical Reporting Ltd has no subsidiary companies.
Ultimate parent company
NATIONAL MEDICAL REPORTING LTD
09713861
NATIONAL MEDICAL REPORTING LTD Shareholders
The largest shareholders in National Medical Reporting Ltd include Azra Yousaf and Mohammed Mian.
azra yousaf
50%
mohammed mian
50%
national medical reporting ltd directors
National Medical Reporting Ltd currently has 2 directors.
The longest serving directors include
Mrs Azra Yousaf (Aug 2015) and
Mr Mohammed Mian (Aug 2015).
national medical reporting ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to national medical reporting ltd.
national medical reporting ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NATIONAL MEDICAL REPORTING LTD. This can take several minutes, an email will notify you when this has completed.
national medical reporting ltdCompanies House Filings - See Documents
